162 related articles for article (PubMed ID: 12393644)
1. Loss of T-lymphocyte clonal dominance in patients with myelodysplastic syndrome responsive to immunosuppression.
Kochenderfer JN; Kobayashi S; Wieder ED; Su C; Molldrem JJ
Blood; 2002 Nov; 100(10):3639-45. PubMed ID: 12393644
[TBL] [Abstract][Full Text] [Related]
2. Response to Hypomethylating Agents in Myelodysplastic Syndrome Is Associated With Emergence of Novel TCR Clonotypes.
Abbas HA; Reville PK; Jiang X; Yang H; Reuben A; Im JS; Little L; Sinson JC; Chen K; Futreal A; Garcia-Manero G
Front Immunol; 2021; 12():659625. PubMed ID: 33912187
[TBL] [Abstract][Full Text] [Related]
3. In-vivo dominant immune responses in aplastic anaemia: molecular tracking of putatively pathogenetic T-cell clones by TCR beta-CDR3 sequencing.
Risitano AM; Maciejewski JP; Green S; Plasilova M; Zeng W; Young NS
Lancet; 2004 Jul 24-30; 364(9431):355-64. PubMed ID: 15276395
[TBL] [Abstract][Full Text] [Related]
4. Haematological response of patients with myelodysplastic syndrome to antithymocyte globulin is associated with a loss of lymphocyte-mediated inhibition of CFU-GM and alterations in T-cell receptor Vbeta profiles.
Molldrem JJ; Jiang YZ; Stetler-Stevenson M; Mavroudis D; Hensel N; Barrett AJ
Br J Haematol; 1998 Sep; 102(5):1314-22. PubMed ID: 9753062
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and clinical association of clonal T-cell expansions in Myelodysplastic Syndrome.
Epling-Burnette PK; Painter JS; Rollison DE; Ku E; Vendron D; Widen R; Boulware D; Zou JX; Bai F; List AF
Leukemia; 2007 Apr; 21(4):659-67. PubMed ID: 17301813
[TBL] [Abstract][Full Text] [Related]
6. Patients with myelodysplastic syndromes display several T-cell expansions, which are mostly polyclonal in the CD4(+) subset and oligoclonal in the CD8(+) subset.
Fozza C; Contini S; Galleu A; Simula MP; Virdis P; Bonfigli S; Longinotti M
Exp Hematol; 2009 Aug; 37(8):947-55. PubMed ID: 19409953
[TBL] [Abstract][Full Text] [Related]
7. Changes in T-cell receptor VB repertoire in aplastic anemia: effects of different immunosuppressive regimens.
Kook H; Risitano AM; Zeng W; Wlodarski M; Lottemann C; Nakamura R; Barrett J; Young NS; Maciejewski JP
Blood; 2002 May; 99(10):3668-75. PubMed ID: 11986222
[TBL] [Abstract][Full Text] [Related]
8. Extensive clonal expansion of T lymphocytes causes contracted diversity of complementarity-determining region 3 and skewed T cell receptor repertoires after allogeneic hematopoietic cell transplantation.
Hirokawa M; Matsutani T; Horiuchi T; Kawabata Y; Kitabayashi A; Yoshioka T; Tsuruta Y; Suzuki R; Miura AB
Bone Marrow Transplant; 2001 Mar; 27(6):607-14. PubMed ID: 11319590
[TBL] [Abstract][Full Text] [Related]
9. Determination of T-cell receptors of clonal CD8-positive T-cells in myelodysplastic syndrome with erythroid hypoplasia.
Matsutani T; Yoshioka T; Tsuruta Y; Shimamoto T; Ohyashiki JH; Suzuki R; Ohyashiki K
Leuk Res; 2003 Apr; 27(4):305-12. PubMed ID: 12531221
[TBL] [Abstract][Full Text] [Related]
10. HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome.
Saunthararajah Y; Nakamura R; Nam JM; Robyn J; Loberiza F; Maciejewski JP; Simonis T; Molldrem J; Young NS; Barrett AJ
Blood; 2002 Sep; 100(5):1570-4. PubMed ID: 12176872
[TBL] [Abstract][Full Text] [Related]
11. Favourable response to antithymocyte or antilymphocyte globulin in low-risk myelodysplastic syndrome patients with a 'non-clonal' pattern of X-chromosome inactivation in bone marrow cells.
Aivado M; Rong A; Stadler M; Germing U; Giagounidis A; Strupp C; Novotny J; Josten KM; Kobbe G; Hildebrandt B; Gattermann N; Aul C; Haas R; Ganser A
Eur J Haematol; 2002 Apr; 68(4):210-6. PubMed ID: 12071936
[TBL] [Abstract][Full Text] [Related]
12. T-cell receptor Vβ skewing frequently occurs in refractory cytopenia of childhood and is associated with an expansion of effector cytotoxic T cells: a prospective study by EWOG-MDS.
Aalbers AM; van den Heuvel-Eibrink MM; Baumann I; Beverloo HB; Driessen GJ; Dworzak M; Fischer A; Göhring G; Hasle H; Locatelli F; De Moerloose B; Noellke P; Schmugge M; Stary J; Yoshimi A; Zecca M; Zwaan CM; van Dongen JJ; Pieters R; Niemeyer CM; van der Velden VH; Langerak AW
Blood Cancer J; 2014 May; 4(5):e209. PubMed ID: 24786393
[TBL] [Abstract][Full Text] [Related]
13. High-throughput sequencing of CD4
Wang L; Zhang P; Li J; Lu H; Peng L; Ling J; Zhang X; Zeng X; Zhao Y; Zhang W
Arthritis Res Ther; 2019 Dec; 21(1):295. PubMed ID: 31856905
[TBL] [Abstract][Full Text] [Related]
14. Molecular strategies for detection and quantitation of clonal cytotoxic T-cell responses in aplastic anemia and myelodysplastic syndrome.
Wlodarski MW; Gondek LP; Nearman ZP; Plasilova M; Kalaycio M; Hsi ED; Maciejewski JP
Blood; 2006 Oct; 108(8):2632-41. PubMed ID: 16614248
[TBL] [Abstract][Full Text] [Related]
15. Inclusion body myositis: clonal expansions of muscle-infiltrating T cells persist over time.
Müntzing K; Lindberg C; Moslemi AR; Oldfors A
Scand J Immunol; 2003 Aug; 58(2):195-200. PubMed ID: 12869141
[TBL] [Abstract][Full Text] [Related]
16. Preferential suppression of trisomy 8 compared with normal hematopoietic cell growth by autologous lymphocytes in patients with trisomy 8 myelodysplastic syndrome.
Sloand EM; Mainwaring L; Fuhrer M; Ramkissoon S; Risitano AM; Keyvanafar K; Lu J; Basu A; Barrett AJ; Young NS
Blood; 2005 Aug; 106(3):841-51. PubMed ID: 15827127
[TBL] [Abstract][Full Text] [Related]
17. [An anti-human ovarian carcinoma and CD3 bispecific single-chain antibody mediates CDR3 spectratype drift of T cell receptor alpha and beta chains].
Luo W; Wen Q; Zhou M; Ma L
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Jun; 32(7):919-23. PubMed ID: 22820567
[TBL] [Abstract][Full Text] [Related]
18. Application of the molecular analysis of the T-cell receptor repertoire in the study of immune-mediated hematologic diseases.
Plasilova M; Risitano A; Maciejewski JP
Hematology; 2003 Jun; 8(3):173-81. PubMed ID: 12745651
[TBL] [Abstract][Full Text] [Related]
19. [Clonal expanded T-cell repertoire in MDS].
Li YQ; DU X
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):793-7. PubMed ID: 20561453
[TBL] [Abstract][Full Text] [Related]
20. Oligoclonal T cell expansion in myelodysplastic syndrome: evidence for an autoimmune process.
Epperson DE; Nakamura R; Saunthararajah Y; Melenhorst J; Barrett AJ
Leuk Res; 2001 Dec; 25(12):1075-83. PubMed ID: 11684279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
